The growing adoption of digital technologies coupled with a sharp rise in cyber threats is fuelling demand for advanced ...

Cambridge biotech Nuclera has further strengthened its financial capability by appointing a new CFO, hot on the heels of the ...

Cambridge biotech Healx stands on the cusp of history after dosing the first patient with a rare and deadly cancer with a ...

Life sciences giant AstraZeneca has supported the global expansion of The Healthcare Businesswomen’s Association into ...

Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British ...

Stansted Airport is on the road to Morocco, or set to take a more stellar highway to be precise. To quote the immortal line ...

Tristel plc, which makes infection prevention products utilising proprietary chlorine dioxide technology, hoisted revenues ...

Sortera Bio Ltd has spun out of the Medical Research Council Laboratory of Molecular Biology (MRC LMB) to pioneer a Deep ...

Luminance, a Cambridge-based pioneer in Legal-Grade™ AI, has raised $75 million in a Series C funding round, taking the total ...

Cambridge-based anti-ageing biotech Shift Bioscience has set up a team and facilities in Canada to serve North America. The ...

Cambridge GaN Devices, a trailblazer in gallium nitride (GaN) power electronics technology, has closed a $32 million Series C ...

Experienced finance chief William J. Kullback has joined the board of Cambridge biotech business Nuclera as a Non Executive ...